NHS
trusts (hospitals) — nurse prescribers
<
Influencers contents
|
Print
this page
Increasing
nursing prescribing levels
Supplementary prescribing
for nurses started in mid-2003 and pharmacists began a similar scheme
at the beginning of 2004. The introduction of supplementary prescribing
by nurses and pharmacists may drastically alter the pattern of care
provision for many patients with long-term health conditions. NHS
chief executives have been asked to ensure that action is taken
forward within their acute trust/PCT as quickly as possible. The
DoHhas also re-posted their guide
for the implementation of supplementary prescribing.
Extended
formulary nurse prescribers
DoH
press release 2003/0179 pointed out that some 50 universities
across the UK are running prescribing courses. But it seems likely
that the government will not get anywhere near its target of 10,000
new nurse prescribers by 2004 (against the Nurse Prescribers’
Extended Formulary (NPEF)). A major obstacle for practice nurses
has been getting time off work to attend lectures because GPs cannot
spare them the costs of courses.
As the NPEF
begins to grow, have a look at the Department’s notes on primary
care prescribing and budget setting (2003-06) which specifically
adds independent nurse prescribers into the mix. See Primary
care prescribing and budget-setting. Prescriptions
issued by practice and community nurses have risen sharply in recent
years from just over a million in 2000 to 2.5m in 2002.
Nurse and pharmacist
prescribing are likely to be amongst the top five NHS issues for
pharmacos in 2004/5 and pharmacists, like nurses, need a new strategy
from companies — from the sales force through NHS influencers
and right through to marketing. The developments here clearly illustrate
that change in this particular area is accelerating. NHS influencers
need to be prepared. As companies continue to formulate their strategies,
there is probably a lot they could do to help out.
NHS influencers
should note that there has been some criticism of the acceleration
in extended nurse prescribing. Professor Alan Maynard from York
University, a leading health economist, has said, ‘The rapid
expansion of nurse prescribing is a social experiment that may seriously
damage both the health of patients and the profits of the industry.’
Extending
independent nurse prescribing within the NHS in England —
a guide for implementation is the sister document
to supplementary prescribing. This 80-page document has everything
that NHS folk need to know about the area. Note that nurses are
reminded that they must make their choice of medicinal product on
the basis of clinical suitability and value for money alone and
that personal gifts are prohibited apart from pens and pads. Both
NPC competency frameworks for prescribing nurses and pharmacists
have material around outside 'influences and influencers'. Also
the NHS is reminded that in nominating for training any nurses whose
posts are directly or indirectly funded by pharmaceutical and other
companies whose products appear in the ENPF, 'necessary steps must
be taken to ameliorate any conflicts of interest'.
The chief nursing
officer’s newsletter for January 2004 had a useful supplement
on nurse prescribing. It said that more than 1,800 nurses were now
qualified and registered to prescribe independently from the Nurse
Prescribers’ Extended Formulary and of these many were trained
as supplementary prescribers. The bulletin reviewed both kinds of
prescribing — saying that the use of PGDs is not a form of
prescribing — and that an additional 30 medicines will be
added to the ENPF, including inhalers for acute asthma attacks and
oral and implant contraceptives. There is also discussion on the
funding of the initiative and the training undergone and linkage
to the Medicines Partnership programme as well as various case studies
and the use of PGDs at the 65 NHS walk-in centres. The CNO bulletin
itself talks about nurse-led services, emergency nurse practitioners
and the role of nurses in new GMS and PMS. See Prescribing:
a supplement of the CNO bulletin on nurse prescribing
The government
has also been considering proposals to allow nurses working in settings
where people need urgent treatment to prescribe oxygen, IV fluids,
pain relief and antihypertensives. The DoH asked nurses working
in critical care, A&E and ‘first contact roles’
in primary care to draw up a list of medications that they would
like to administer without needing a doctor’s prescription
under PGDs. There will also be further development of national templates
for PGDs for treatments.
Note the DoH
page on independent
nurse prescribing, which includes an update on central
funds for training.
Further
information >
The DrugInfoZone
website features useful content on both supplementary
prescribing and PGDs, including:
Extending
the formulary
It is likely that the ENPF will continue to be extended. Some notes
on further extending independent nurse prescribing and a useful
list of all the proposed new POMs can be found on the DoH site under
nurse
prescribing.
The Home Office
has considered proposals for independent nurse prescribers to be
able to prescribe schedule two and three drugs — diamorphine,
methodone, buprenorphine, etc — used particularly to treat
heroin addiction as well as allowing nurses to supply controlled
drugs under patient group directions. This would enable nurses in
A&E and coronary care to supply diamorphine for cardiac pain
and all nurses to supply benzodiazepines and OTC drugs containing
low-dose opiates. As already mentioned, plans have also been announced
to extend the scope of nurse prescribing to both the emergency treatment
of asthma and diabetes; pain relief in midwifery practice and coronary
care; the treatment of chlamydia, implantable contraceptives and
the relief of symptoms of menopause. See Items
prescribable by nurses through the Nurse Prescribers’ Extended
Formulary.
Finally, nurses
and pharmacists are set to learn prescribing skills side-by side
on a new course on supplementary prescribing being developed by
St Bart’s School of Nursing at City University and the School
of Pharmacy at the University of London.
|